Contact Information
617-500-2537 (direct)
617-500-2499 (fax) Widom@ORTpatent.com

Industries
  • Biotechnology
  • Genetics
  • Molecular Biology
  • Pharmaceutical


Firm Directory Links
Partners
Frank R. Occhiuti
J. Robin Rohlicek, Ph.D.
Y. Rocky Tsao, Ph.D.

Of Counsel, Associates, Technology Specialists, & Scientific Advisors
Faustino A. Lichauco
Elliott J. Mason, Ph.D.
Kelly McGlashen
Zach Rimkunas
Russell Widom, Ph.D.
Jeannie Wu, Ph.D.
Firm Directory
Russell Widom, Ph.D.
Patent Agent
Russell's practice focuses on patent prosecution in the areas of pharmaceuticals and biotechnology.

Professional Experience
Russell was a Research Fellow in Cardiology at Children’s Hospital, Boston, affiliated with Harvard Medical School. His work focused on regulation of lipoprotein gene expression. He then moved to the Rheumatology section of Boston University School of Medicine as an Assistant Professor of Medicine and Biochemistry, where he directed a research group studying the autoimmune disease scleroderma.

Education
Ph.D., Biology, City University of New York
A.B., Biology/Biochemistry, Cornell University

Bar Admissions
Registered to practice before the United States Patent and Trademark Office

Selected Publications and Presentations
Renard, E., C.Chadjichristos, M.Kypriotou,G.Beauchef, P.Bordat, A.Dompmartin, R.L. Widom, K.Boumediene, J.-P.Pujol, P.Galera. 2008. Chondroitin sulfate decreases collagen synthesis in normal and scleroderma fibroblasts through a Smad independent TGF-B pathway- Implication of C-Krox and Sp1. J. Cellular and Molecular Medicine 12:2836-47

Kypriotou, M., G.Beauchef, C.Chadjichristos, R.Widom, E.Renard, S.A.Jimenez, J.Korn, F.-X.Maquart, O.Thierry, O.Von Stetten, J.-P.Pujol, P.Galera. 2007. Human Collagen-Krox (hc-Krox) up-regulates type I collagen expression in normal and scleroderma fibroblasts through interaction with Sp1 and Sp3 transcription factors. J. Biol. Chem. 282:32000-32014.

Yamin, R., S. Bagchi, R. Hildebrant, A. Scaloni, R.L. Widom, C.R. Abraham. 2007. Acyl peptide hydrolase, a serine proteinase isolated from conditioned medium of neuroblastoma cells, degrades the amyloid-B peptide. J. Neurochem. 100 (2), 458–467.

Farina, G., R. Lemaire, J.H. Korn, R.L. Widom. 2006. Cartilage Oligomeric Matrix Protein is Overexpressed by Scleroderma Dermal Fibroblasts. Matrix Biology 25:213-222.